5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-5-(2,4-DIFLUOROPHENYL)TETRAHYDROFURAN-3-YL)METHYL 4-CHLOROBENZENESULFONATE, ((3S,5R)-
UNII R9E6N64SKT
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-chlorobenzenesulfonate, ((3s,5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R9E6N64SKT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 175712-02-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H18ClF2N3O4S WUPORSBDFSRGHD-XOBRGWDASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-chlorobenzenesulfonate, ((3s,5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.